Literature DB >> 18555188

Modeling cardiovascular disease in the zebrafish.

Timothy J A Chico1, Philip W Ingham, David C Crossman.   

Abstract

The zebrafish possesses a host of advantages that have established it as an excellent model of vertebrate development. These include ease of genetic manipulation and transgenesis, optical clarity, and small size and cost. Biomedical researchers are increasingly exploiting these advantages to model human disease mechanisms. Here we review the use of the zebrafish for cardiovascular research. We summarize previous studies with the use of this organism to model such processes as thrombosis, collateral vessel development, inflammation, cardiomyopathy, and cardiac regeneration, evaluate its promise for novel drug discovery, and consider where the zebrafish fits into the framework of existing cardiovascular models.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18555188     DOI: 10.1016/j.tcm.2008.04.002

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  32 in total

1.  Effects of the Dietary ω3:ω6 Fatty Acid Ratio on Body Fat and Inflammation in Zebrafish (Danio rerio).

Authors:  Mickie L Powell; Melissa A Pegues; Alexander J Szalai; Vithal K Ghanta; Louis R D'Abramo; Stephen A Watts
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

2.  A new model system swims into focus: using the zebrafish to visualize intestinal metabolism in vivo.

Authors:  Juliana D Carten; Steven A Farber
Journal:  Clin Lipidol       Date:  2009-08-01

3.  Variation in wall shear stress in channel networks of zebrafish models.

Authors:  Woorak Choi; Hye Mi Kim; Sungho Park; Eunseop Yeom; Junsang Doh; Sang Joon Lee
Journal:  J R Soc Interface       Date:  2017-02       Impact factor: 4.118

4.  Embryonic Stem Cells as a Model for Cardiac Development and Disease.

Authors:  Todd Evans
Journal:  Drug Discov Today Dis Models       Date:  2008

Review 5.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

6.  Optical assessment of the cardiac rhythm of contracting cardiomyocytes in vitro and a pulsating heart in vivo for pharmacological screening.

Authors:  Yu-Cheng Lai; Wei-Tien Chang; Kuen-You Lin; Ian Liau
Journal:  Biomed Opt Express       Date:  2014-04-23       Impact factor: 3.732

7.  GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGFβ signaling.

Authors:  Andy Willaert; Sandeep Khatri; Bert L Callewaert; Paul J Coucke; Seth D Crosby; Joseph G H Lee; Elaine C Davis; Sruti Shiva; Michael Tsang; Anne De Paepe; Zsolt Urban
Journal:  Hum Mol Genet       Date:  2011-11-24       Impact factor: 6.150

Review 8.  Advancements in zebrafish applications for 21st century toxicology.

Authors:  Gloria R Garcia; Pamela D Noyes; Robert L Tanguay
Journal:  Pharmacol Ther       Date:  2016-03-22       Impact factor: 12.310

9.  Analysis of postembryonic heart development and maturation in the zebrafish, Danio rerio.

Authors:  Corinna Singleman; Nathalia G Holtzman
Journal:  Dev Dyn       Date:  2012-11-05       Impact factor: 3.780

10.  Characterization of vascular mural cells during zebrafish development.

Authors:  Massimo M Santoro; Gabriella Pesce; Didier Y Stainier
Journal:  Mech Dev       Date:  2009-06-17       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.